Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,133Revenue (TTM) $M124Net Margin (%)-128.6Altman Z-Score1.1
Enterprise Value $M4,936EPS (TTM) $-0.7Operating Margin %-79.6Piotroski F-Score6
P/E(ttm)--Beneish M-Score3.7Pre-tax Margin (%)-128.5Higher ROA y-yY
Price/Book15810-y EBITDA Growth Rate %--Quick Ratio2.1Cash flow > EarningsY
Price/Sales34.35-y EBITDA Growth Rate %--Current Ratio2.1Lower Leverage y-yY
Price/Free Cash Flow48.6y-y EBITDA Growth Rate %--ROA % (ttm)-36.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M286ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with EXEL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EXELJoel Greenblatt 2016-09-30 Add0.02%$8.04 - $15.48
($10.81)
$ 17.9266%Add 498.39%130,059
EXELJoel Greenblatt 2016-06-30 Buy $4 - $7.85
($5.74)
$ 17.92212%New holding21,735
EXELCharles Brandes 2016-03-31 Sold Out $3.64 - $5.64
($4.25)
$ 17.92322%Sold Out0
EXELCharles Brandes 2015-12-31 Reduce$4.79 - $6.33
($5.59)
$ 17.92221%Reduce -44.88%14,000
EXELCharles Brandes 2015-06-30 Buy $2.57 - $4.03
($3.24)
$ 17.92453%New holding25,400
EXELFirst Eagle Investment 2014-06-30 Sold Out -0.0038%$3.22 - $3.8
($3.45)
$ 17.92419%Sold Out0
EXELFirst Eagle Investment 2014-03-31 Reduce-0.01%$3.38 - $8.24
($6.84)
$ 17.92162%Reduce -65.91%400,000
EXELFirst Eagle Investment 2012-09-30 Add0.02%$4.28 - $6.45
($5.29)
$ 17.92239%Add 422.58%1,175,800
EXELFirst Eagle Investment 2012-03-31 Add$4.49 - $6.47
($5.14)
$ 17.92249%Add 125.00%225,000
EXELFirst Eagle Investment 2011-12-31 Buy $3.95 - $7.81
($5.01)
$ 17.92258%New holding100,000
EXELCarl Icahn 2011-09-30 Sold Out -0.43%$5.5 - $9.22
($7.34)
$ 17.92144%Sold Out0
EXELFirst Eagle Investment 2011-03-31 Sold Out -0.01%$7.22 - $12.45
($9.95)
$ 17.9280%Sold Out0
EXELFirst Eagle Investment 2010-12-31 Buy 0.01%$3.98 - $9.08
($5.66)
$ 17.92217%New holding280,000
EXELFirst Eagle Investment 2009-12-31 Sold Out -0.02%$5.33 - $8
($6.84)
$ 17.92162%Sold Out0
EXELFirst Eagle Investment 2009-09-30 Buy 0.02%$4.4 - $6.99
($5.65)
$ 17.92217%New holding274,700
EXELFirst Eagle Investment 2009-06-30 Sold Out -0.01%$4.16 - $5.55
($4.87)
$ 17.92268%Sold Out0
EXELFirst Eagle Investment 2009-03-31 Reduce$4.32 - $5.85
($4.8)
$ 17.92273%Reduce -25.67%144,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EXEL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


EXEL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lamb PeterEVP, Scientific Strategy & CSO 2017-01-03Sell70,000$14.6522.32view
FELDBAUM CARL BDirector 2016-12-16Sell25,000$17.035.23view
Garber Alan MDirector 2016-12-09Sell7,832$16.96.04view
SCANGOS GEORGE ADirector 2016-12-07Sell204,894$17.810.62view
Lamb PeterEVP, Scientific Strategy & CSO 2016-12-01Sell70,000$16.667.56view
Schwab GiselaPres Prod Dev & Med Aff & CMO 2016-12-01Sell22,000$16.737.11view
MORRISSEY MICHAELPresident and CEO 2016-11-09Sell200,000$1519.47view
Schwab GiselaPres Prod Dev & Med Aff & CMO 2016-11-09Sell22,000$1519.47view
Lamb PeterEVP, Scientific Strategy & CSO 2016-11-09Sell70,000$13.1536.27view
Schwab GiselaPres Prod Dev & Med Aff & CMO 2016-08-31Sell131,155$10.9863.21view

Quarterly/Annual Reports about EXEL:

News about EXEL:

Articles On GuruFocus.com
Top Performing Contest Portfolios from 2016 Jan 17 2017 
7 Stocks Outperforming the Market Jan 12 2017 
Why You Should Be Using the Altman Z-Score Dec 18 2016 
The Best-Performing Non-S&P Stocks of 2015 Dec 30 2015 
5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic Communications Inc, and Aeropostale I Dec 28 2014 
5-year lows: National Presto Industries, Ennis Inc, Landauer Inc, and Exelixis Inc. Sep 28 2014 
Weekly 3-Year Low Highlights: UAN, CLD, EXEL, QNST Sep 06 2014 
Five-Year Lows: Rentech Nitrogen Partners LP, SandRidge Permian Trust, Millennial Media Inc., Exelix May 05 2014 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
Exelixis Inc. Reports Operating Results (10-K) Feb 22 2011 

More From Other Websites
Exelixis, Inc. – Value Analysis (NASDAQ:EXEL) : January 11, 2017 Jan 11 2017
4 Stocks in Focus as Biotech M&A Hopes Surge on Takeda-ARIAD Deal Jan 10 2017
Genentech Withdraws Cost Claims Against Exelixis Jan 10 2017
Exelixis, Inc. breached its 50 day moving average in a Bullish Manner : EXEL-US : January 10, 2017 Jan 10 2017
Update on Dispute between Exelixis and Genentech, a Member of the Roche Group Jan 09 2017
Biotech Stocks to Watch in 2017 ACADIA Pharmaceuticals and Exelixis Jan 04 2017
How calls are looking for Exelixis rally Jan 04 2017
Exelixis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Jan 03 2017
Exelixis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Jan 03 2017
ETFs with exposure to Exelixis, Inc. : January 3, 2017 Jan 03 2017
Exelixis, Inc. breached its 50 day moving average in a Bearish Manner : EXEL-US : December 30, 2016 Dec 30 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)